Literature DB >> 11017148

Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells.

T Kikuchi1, S Worgall, R Singh, M A Moore, R G Crystal.   

Abstract

We have investigated whether dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can trigger B cells to produce antigen-specific antibodies without CD4+ T-cell help. Dendritic cells modified with a recombinant adenovirus vector to express CD40 ligand and pulsed with heat-killed Pseudomonas induced naive B cells to produce antibodies against Pseudomonas in the absence of CD4+ T cells in vitro, initiated Pseudomonas-specific humoral immune responses in vivo in wild-type and CD4-/- mice, and protected immunized wild-type and CD4-/-, but not B-cell -/- mice, from lethal intrapulmonary challenge with Pseudomonas. Thus, genetic modification of dendritic cells with CD40 ligand enables them to present a complex mixture of microbial antigens and establish CD4+ T cell-independent, B cell-mediated protective immunity against a specific microbe.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017148     DOI: 10.1038/80498

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  24 in total

1.  Expression of surface CD40 and immunocytochemical actin-bundling protein fascin in dendritic cells from multiple myeloma treated with retinoids during their differentiation in vitro.

Authors:  M Chiriva-Internati; F Grizzi; B Franceschini; P L Hermonat; S Lim; N Dioguardi; F M Rodriguez
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Nov-Dec       Impact factor: 2.416

2.  Inhibition of B-cell death does not restore T-cell-dependent immune responses in CD40-deficient mice.

Authors:  Jesús Merino; Miguel A Díez; María Muñiz; Luis Buelta; Gabriel Núñez; Marcos López-Hoyos; Ramón Merino
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

3.  Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.

Authors:  Toshiaki Kikuchi; Sita Andarini; Hong Xin; Kazunori Gomi; Yutaka Tokue; Yasuo Saijo; Tasuku Honjo; Akira Watanabe; Toshihiro Nukiwa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  CD4+ T cell-independent DNA vaccination against opportunistic infections.

Authors:  Mingquan Zheng; Alistair J Ramsay; Myles B Robichaux; Corrine Kliment; Christopher Crowe; Rekha R Rapaka; Chad Steele; Florencia McAllister; Judd E Shellito; Luis Marrero; Paul Schwarzenberger; Qiu Zhong; Jay K Kolls
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

5.  CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.

Authors:  M Zheng; J E Shellito; L Marrero; Q Zhong; S Julian; P Ye; V Wallace; P Schwarzenberger; J K Kolls
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

6.  Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.

Authors:  S Worgall; T Kikuchi; R Singh; K Martushova; L Lande; R G Crystal
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice.

Authors:  M Wu; S Hussain; Y H He; R Pasula; P A Smith; W J Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

8.  Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen.

Authors:  Wei Li
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

9.  Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154.

Authors:  Sharmila Manoj; Philip J Griebel; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

10.  Immunotherapy of tumors with recombinant adenovirus encoding macrophage inflammatory protein 3beta induces tumor-specific immune response in immunocompetent tumor-bearing mice.

Authors:  Jian-mei Hou; Xia Zhao; Ling Tian; Gang Li; Ru Zhang; Bing Yao; Hong-xin Deng; Jin-liang Yang; Yu-quan Wei
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.